Moleculin Biotech, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $29.0M
Liabilities Breakdown FY2020
Total Liabilities: $11.3M
Asset Breakdown
Total Assets: $29.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $15.2M | 52.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $483.0K | 1.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $13.4M | 46.1% |
Liabilities Breakdown
Total Liabilities: $11.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 10.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.1M | 90.0% |